ICI efficacy information portal: a knowledgebase for responder prediction to immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) have led to durable responses in cancer patients, yet their efficacy varies significantly across cancer types and patients. To stratify patients based on their potential clinical benefits, there have been substantial research efforts in identifying biomarkers and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiamin, Rebibo, Daniel, Cao, Jianquan, Mok, Simon Yat-Man, Patel, Neel, Tseng, Po-Cheng, Zhang, Zhenghao, Yip, Kevin Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cancer Data Resource
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984987/
https://www.ncbi.nlm.nih.gov/pubmed/36879684
http://dx.doi.org/10.1093/narcan/zcad012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984987/
https://www.ncbi.nlm.nih.gov/pubmed/36879684
http://dx.doi.org/10.1093/narcan/zcad012

Ejemplares similares